We’re excited to announce that iwMyeloma 2023, the 16th workshop exploring myeloma biology and innovation, will take place in person on 17–19 March, at the Meliá Castilla Hotel, Madrid, Spain. In keeping with the ethos of iwMyeloma, the emphasis of the workshop will be on short, high-level presentations, sessions of interactive debate and panel discussions.
iwMyeloma is an annual workshop/think-tank bringing together leading international clinical and translational research minds in multiple myeloma in a face-to-face forum. Discussions around the current state-of-the-art in clinical care and research aim to set the agenda for clinical and translational research priorities for the future, in collaboration with relevant stakeholders. Objectives are:
- Create annual opportunity for scientific exchange of ideas, knowledge, and research in multiple myeloma
- Enhance networking and inter-disciplinary collaborations
- Create a platform for a united voice from scientific/research community to provide focused input into the research priorities
- Improve clinical trial design and conduct to be more efficient and inclusive through robust interactions with industry partners, regulators, and patient advocacy groups
Our Media Partner
We are pleased to have the Video Journal of Hematological Oncology (VJHemOnc) be our official media partner, providing on-demand coverage that can be viewed in the Meeting Highlights tab.
VJHemOnc is a global, open-access video journal, dedicated to providing trusted and up-to-date independent medical information in order to improve the awareness of advances in the management of hematological cancers and share best practice within the HemOnc community.
The goal of the journal is to expedite learning through the sharing of new data and expert opinion, and to rapidly disseminate the latest news and information to healthcare professionals, worldwide, on a range of innovative digital media – including video and blog formats.
VJHemOnc content is led by an editorial board of highly respected thought leaders with a combined expertise that spans the spectrum of hematological cancers. All content is created and published under the guidance of this board of world-leading experts.
For more information please see www.VJHemOnc.com
If you are interested in becoming a supporter of the 16th iwMyeloma International Workshop, please contact us here